Skye Bioscience, Inc. (SKYE)
NASDAQ: SKYE · Real-Time Price · USD
0.736
-0.025 (-3.31%)
At close: Mar 3, 2026, 4:00 PM EST
0.702
-0.034 (-4.67%)
Pre-market: Mar 4, 2026, 6:15 AM EST
Skye Bioscience Stock Forecast
SKYE's stock price has decreased by -74.18% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Skye Bioscience stock have an average target of 14.75, with a low estimate of 10 and a high estimate of 20. The average target predicts an increase of 1,904.35% from the current stock price of 0.74.
Analyst Consensus: Strong Buy
* Price targets were last updated on Sep 30, 2025.
Analyst Ratings
The average analyst rating for Skye Bioscience stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 4 | 4 | 4 | 4 | 4 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $20 | Strong Buy | Initiates | $20 | +2,617.76% | Sep 30, 2025 |
| Evercore ISI Group | Evercore ISI Group | Buy Initiates $10 | Buy | Initiates | $10 | +1,258.88% | Aug 15, 2025 |
| JMP Securities | JMP Securities | Buy Reiterates $15 | Buy | Reiterates | $15 | +1,938.32% | Jun 24, 2025 |
| Craig-Hallum | Craig-Hallum | Strong Buy Maintains $18 → $14 | Strong Buy | Maintains | $18 → $14 | +1,802.43% | Mar 21, 2025 |
| Citizens Capital Markets | Citizens Capital Markets | Buy Reiterates $15 | Buy | Reiterates | $15 | +1,938.32% | Mar 21, 2025 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.42
from -0.73
EPS Next Year
-1.09
from -1.42
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | n/a | n/a | ||||
| Avg | n/a | n/a | ||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -1.31 | -0.66 | ||||
| Avg | -1.42 | -1.09 | ||||
| Low | -1.67 | -1.40 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.